Company now holds two-thirds of its $3B in assets in crypto, embracing a bold Bitcoin treasury strategy
Trump Media & Technology Group (DJT) surged over 5% on Monday after the company announced it had acquired $2 billion in Bitcoin and related digital assets, solidifying its transition into a bitcoin treasury company. The move marks a significant escalation in the firm’s crypto ambitions, with Bitcoin now comprising two-thirds of its $3 billion in total assets.
The parent company of Truth Social, streaming service Truth+, and fintech platform Truth.Fi, Trump Media originally laid out its crypto strategy in May, aiming to mirror the approach pioneered by Michael Saylor’s Strategy (formerly MicroStrategy). That model involves using a mix of equity and debt to aggressively accumulate Bitcoin as a long-term store of value.
“We’re rigorously implementing our publicly announced strategy and fulfilling our bitcoin treasury plan,” said Devin Nunes, CEO of Trump Media, in a press release. “These assets help ensure our company’s financial freedom, protect us against discrimination by financial institutions, and will create synergies with the utility token we’re planning to introduce across the Truth Social ecosphere.”
The company’s deepening investment in crypto coincides with favorable regulatory shifts in Washington. On Friday, former President Trump signed into law the first federal framework for dollar-backed stablecoins, a move expected to boost institutional adoption of digital assets. In parallel, Trump-backed World Liberty Financial recently launched its own stablecoin, USD1, in partnership with BitGo.
Despite Monday’s rally, Trump Media shares remain down 25% since announcing the Bitcoin strategy in May and 45% year-to-date. While the bold crypto play has excited some retail investors, skeptics question the long-term viability amid intense market volatility and persistent short seller pressure.
Still, Trump Media’s aggressive pivot into crypto sets the company apart in the evolving landscape of digital finance.
You might like this article:ProMIS Neurosciences Soars 160% After FDA Fast Track Designation for Alzheimer’s Drug
